Wednesday, March 16, 2022

UKRAINE AND LONG TERM CONSEQUENCES OF THE RUSSIAN INVASION

DOUG BANDOW is a senior fellow at the Cato Institute, specializing in foreign policy and civil liberties.

WEBSITE: https://www.cato.org/

Bandow worked as special assistant to President Ronald Reagan and editor of the political magazine Inquiry. He writes regularly for leading publications such as Fortune magazine,

THE LATEST ON CORONAVIRUS AND PENDING FDA AND CDC APPROVAL OF VACCINES

PETER PITTS is President and co-founder of the Center for Medicine in the Public Interest and former Food and Drug Administration Associate Commissioner.

WEBSITE: https://cmpi.org/

HIS BOOK:

THE NEXT NORMAL, by Peter J. Pitts (Author)

Publisher: ‎ Lulu.com (January 5, 2022)

Over the course of the COVID-19 pandemic, billions of people in every corner of the globe have questioned what the “New” Normal will look like. There’s a fundamental flaw with the premise of this query. When it comes to healthcare what lies just around the corner is never the “New” Normal, but rather the “Next” Normal. Healthcare will always be in a state of change. In this book, former FDA associate commissioner Peter J. Pitts offers incisive commentary on how we can navigate this forward course with science as our guide. The featured articles call for renewed focus on a host of subjects ranging from health literacy and intellectual property protections, to regulatory roadblocks and cutting-edge engineering. In a time of boundless opportunities — and threats — The Next Normal is essential reading for us all.

Prior to founding CMPI, Pitts was a Senior Fellow for healthcare studies at the Pacific Research Institute. Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He supervised FDA’s Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management. He served on the agency’s obesity working group and counterfeit drug taskforce. His book, Become Strategic or Die, is widely recognized as a cutting edge study of how leadership, in order to be successful over the long term, must be combined with strategic vision and ethical practice. He is the editor of the new book, Coincidence or Crisis, a discussion of global prescription medicine counterfeiting.

He has served as an adjunct professor at Indiana University’s School of Public and Environmental Affairs and Butler University. Mr. Pitts also currently serves as a Visiting Professor at University of Paris School of Medicine.